Lifastuzumab vedotin — properties from Wikipedia — wikidata.cheminfo.org

Lifastuzumab vedotinLifastuzumab vedotin (INN; development code DNIB0600A) is an experimental monoclonal antibody-drug conjugate designed for the treatment of cancer. Read from the Drugbox of the Wikipedia article Lifastuzumab vedotin, revision 1370568769.

Property

Value

Formula

C6504H10028N1744O2018S46, 146414.93 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.

Search — compounds by structure and property

About — sources, licence, and how to cite

Status — the daily update

API documentation

Our other tools

learn.cheminfo.org

inchi.cheminfo.org

vcl.cheminfo.org

smiles.cheminfo.org

iupac-name.cheminfo.org

openbabel.cheminfo.org

www.chemcalc.org

dbe.cheminfo.org

metabo.nmrium.com

derepflow.cheminfo.org

surge.cheminfo.org

tex.cheminfo.org

lcao.cheminfo.org

regexp.cheminfo.org

pdb.cheminfo.org

elucidation.cheminfo.org

equilibrium.cheminfo.org

polycarp.cheminfo.org

3d.cheminfo.org

periodic-table.cheminfo.org

database.cheminfo.org

symmetry.cheminfo.org

osiris.cheminfo.org

atoms.cheminfo.org

moles.cheminfo.org

inorganic.cheminfo.org

powerpoint.cheminfo.org